You are here

lung cancer

Real-World Data on Medtronic's Lung Cancer Device Is Promising

Real-World Data on Medtronic's Lung Cancer Device Is Promising

Medical Devices and Diagnostics Industry

electromagnetic navigation bronchoscopy

Flag link:

A New Collaboration Could Be Key in the Early Detection of Lung Cancer

A New Collaboration Could Be Key in the Early Detection of Lung Cancer

Medical Devices and Diagnostics Industry

Flag link:

OncoCyte's lung cancer liquid biopsy test shows 90% sensitivity

OncoCyte's lung cancer liquid biopsy test shows 90% sensitivity

BioCentury

Flag link:

Veracyte Finds Ally in J&J for Early Lung Cancer Detection

Veracyte Finds Ally in J&J for Early Lung Cancer Detection

Medical Devices and Diagnostics Industry

genomic diagnostics

Flag link:

New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases

New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases

BioSpace

Bristol-Myers Squibb

Flag link:

Boehringer employees go door-to-door delivering holiday hope to lung cancer patients

Boehringer employees go door-to-door delivering holiday hope to lung cancer patients

Fierce Pharma

Boehringer Ingelheim

Flag link:

AbbVie suffers fresh setback with lung cancer drug Rova-T

AbbVie suffers fresh setback with lung cancer drug Rova-T

Pharmaforum

Flag link:

One more shot at slowing Keytruda’s first-line lung cancer domination

One more shot at slowing Keytruda’s first-line lung cancer domination

EP Vantage

Flag link:

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years

BioSpace

Ariad Pharmaceuticals

Boehringer Ingelheim

Bristol-Myers Squibb

Puma Biotechnology

Flag link:

Common Blood Pressure Medication Linked To Increased Risk Of Lung Cancer

Common Blood Pressure Medication Linked To Increased Risk Of Lung Cancer

Forbes

Flag link:

Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study

Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer Study

BioSpace

Bristol-Myers Squibb

Flag link:

Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases

Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases

CP Wire

Percepta Bronchial Genomic Classifier

Flag link:

Veracyte to Present Data Supporting Use of Their Non-Invasive Diagnostics for Lung Diseases

Flag link:

Clovis Oncology to Pay the SEC $20 Million for Misleading Investors

Clovis Oncology to Pay the SEC $20 Million for Misleading Investors

BioSpace

Clovis Oncology

Flag link:

Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field

Johnson & Johnson raises a flag in early-stage lung cancer with first-ever contest in the field

Fierce Pharma

drug development

Flag link:

In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer

In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer

Endpoints

Flag link:

Roche's Alecensa latest beneficiary of faster China drug approvals

Roche's Alecensa latest beneficiary of faster China drug approvals

Reuters

Alecensa. China

Flag link:

Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third

Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third

Fierce Pharma

PD-1 inhibitors

Flag link:

How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab

How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab

Forbes

type 2 diabetes

Flag link:

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

Endpoints

Flag link:

Pages